IAA-L-Leu

IAA-L-Leu is an L-leucine-derived amino acid derivative in which the amino acid side chain bears an iodinated aromatic substituent, yielding a chiral, halogenated building block suitable for stereochemically defined chemistry. The molecule retains the L-configured α-amino acid stereocenter and presents a carboxyl functionality that can be used in peptide coupling after appropriate activation or protection-state adjustment. The iodinated aromatic motif introduces strong mass- and spectroscopic observability, while the amine and carboxyl groups enable controlled formation of amide bonds and downstream derivatization. The overall reactivity profile supports use as a labeled or functionalized amino acid intermediate for constructing peptide analogs, conjugates, and analytical standards where iodine-containing stereodefined fragments are required.

1. Peptide Synthesis

IAA-L-Leu is applied in peptide building block preparation where the L-leucine backbone provides a well-defined α-amino acid geometry for amide bond formation. The derivative's carboxyl group can be converted into activated coupling forms, while the amino functionality can be managed through protection-group strategies compatible with standard peptide coupling chemistries. The iodinated aromatic side-chain element functions as a structural handle for mass spectrometry tracking and for selective downstream transformations that preserve the chiral center. Peptide coupling compatibility enables incorporation into short peptide sequences and peptidomimetic scaffolds for structure-verified synthesis and side-chain functional studies in synthetic organic chemistry.

2. Chemical Biology Labeling

IAA-L-Leu is suitable for chemical biology research that benefits from iodine-containing tags for sensitive detection and fragment-level characterization. The chiral L-leucine framework supports incorporation into peptide-like structures, while the iodinated aromatic substituent provides a strong signal in analytical workflows such as LC-MS and iodine-specific detection approaches. The amino acid's functional groups support conjugation strategies that maintain stereochemical fidelity, including formation of amide-linked probes or attachment through controlled deprotection and coupling steps. Labeled derivatives generated from IAA-L-Leu can serve as biochemical research intermediates for studying binding-site interactions, degradation pathways, and molecular recognition at the level of tagged fragments.

3. SAR And Molecular Design

IAA-L-Leu is used in structure-activity relationship studies and fragment-based molecular design where controlled side-chain modification is required on a leucine-derived scaffold. The maintained L-configuration at the α-carbon supports stereochemically consistent analog series, while the iodinated aromatic substituent enables systematic variation of electronic and steric properties without altering the core amino acid topology. The carboxyl and amino functionalities enable conversion into protected intermediates for sequential assembly into analog libraries, including peptide-like constructs and constrained peptidomimetics. Downstream derivatives prepared from IAA-L-Leu can be applied to SAR workflows that rely on reproducible stereochemical placement of functional groups and traceable analytical behavior.

4. Protected Amino Acid Chemistry

IAA-L-Leu is applied as a chiral amino acid intermediate in protected amino acid synthesis where selective handling of the α-amino and carboxyl functionalities is required. The derivative's functional group set supports protection-state engineering to enable orthogonal deprotection sequences during multi-step peptide construction or conjugate assembly. The iodinated aromatic substituent can be retained under conditions that preserve the stereocenter, supporting iterative derivatization and controlled side-chain retention for labeled peptide analogs. The resulting protected or activated forms can be used as process-ready intermediates for fine chemical synthesis routes that demand stereochemical control and predictable coupling behavior.

5. Pharmaceutical Intermediate Preparation

IAA-L-Leu is suitable for pharmaceutical intermediate preparation in the context of nonclinical research reagent synthesis and medicinal chemistry supply chains that require defined chiral building blocks. The L-leucine-derived backbone provides a stereochemically consistent platform for generating amide-linked intermediates, while the iodinated aromatic motif supports downstream analytical verification and structural confirmation during manufacturing-scale synthesis. The amino acid's reactive functionalities enable conversion into coupling-ready derivatives that can feed into peptide-like inhibitors, scaffold fragments, or labeled reference materials. Industrial chemical manufacturing workflows can employ IAA-L-Leu as a chiral, iodine-bearing intermediate for controlled synthesis of structured molecules where traceable aromatic halogen content is beneficial.

6. Analytical Research Standards

IAA-L-Leu is used for analytical research and method development where iodine-containing amino acid derivatives improve detectability and confirm identity of complex mixtures. The chiral L-leucine framework supports stereochemically defined standards, while the iodinated aromatic substituent provides a distinctive mass signature for LC-MS and related spectrometric characterization. Functional group reactivity enables preparation of reference derivatives, including amide-linked standards and conjugate forms that mimic expected sample analytes. Analytical standards derived from IAA-L-Leu can support routine quantitation, impurity profiling, and structural verification in amino acid derivative development and peptide science workflows.

1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes